October 27, 2014

The National Association of Drug Diversion Investigators on Friday highlighted the latest results achieved by Alabama's real-time, stop-sale pseudoephedrine tracking system.

July 11, 2014

CVS/pharmacy replaced single-ingredient pseudoephedrine products with the tamper-resistant PSE product, Zephrex-D, in all of its West Virginia stores, as well as stores in nearby states that are located within 15 miles of West Virginia's border, including Kentucky, Maryland, Ohio, Pennsylvania and Virginia.

 

With the move, West Virginia has become a de facto test market for the diversion-defiant PSE formulation, because along with CVS/pharmacy, Rite Aid and Fruth and soon Walgreens will all be selling similar formulations. The move sends a stern message to West Virginian methamphetamine makers to the tune of Tom Petty's "Don't come around here no more."

June 11, 2014

The West Virginia Retailers Association on Tuesday issued testimony that the National Precursor Log Exchange (NPLEx) works in curbing the diversion of pseudoephedrine into methemphetamine.

January 3, 2014

Fruth Pharmacy is seeing a positive response from customers in its efforts to limit the sale of OTC cold and allergy medications that contain pseudoephedrine, according to published reports.

November 20, 2013

Through mid-November, a national registry of over-the-counter drugs considered chemical precursors to methamphetamine prevented more than 16,700 boxes of the drugs from being sold illegally.

November 6, 2013

Rite Aid has stopped selling some cold medicines containing pseudoephedrine at its stores in West Virginia, according to published reports.

November 5, 2013

Acura Pharmaceuticals on Monday announced that Nexafed, its next generation pseudoephedrine with abuse-deterrent technology, will now be stocked by Rite Aid.

September 27, 2013

ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.

August 28, 2013

The Consumer Healthcare Products Association on Wednesay applauded Delaware Rep. Rebecca Walker, the Delaware legislature and Gov. Jack Markell for passing and signing House Bill 130, an anti-methamphetamine bill.

August 28, 2013

Fruth Pharmacy is taking up a pseudoephedrine product for nasal congestion designed to deter the manufacturing of methamphetamine at all of its stores, according to published reports.

August 8, 2013

Pennsylvania last month became the 29th state to employ the National Precursor Log Exchange in the fight against the diversion of products containing pseudoephedrine into methamphetamine. State No. 30, Delaware, is expected to sign real-time stop sale technology into law this summer.

July 15, 2013

Acura Pharmaceuticals on Monday announced a second-generation prototype formulation of its methamphetamine-resistant IMPEDE technology with pseudoephedrine hydrochloride yielded no measurable amount of methamphetamine hydrochloride when processed in the direct conversion or one-pot method.

July 10, 2013

The Consumer Healthcare Products Association on Wednesday applauded the Pennsylvania legislature and Gov. Tom Corbett for passage of House Bill 602, legislation requiring real-time, stop-sale technology to enable retailers to block illegal pseudoephedrine purchases at the point of sale.

June 6, 2013

The Consumer Healthcare Products Association on Thursday applauded the Vermont legislature and Gov. Peter Shumlin for their passage of House Bill 522, which makes Vermont the 27th state to adopt the pseudoephedrine-tracking system known as the National Precursor Log Exchange.

May 31, 2013

Fruth Pharmacy announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

May 30, 2013

Westport Pharmaceuticals announced findings from independent testing of their meth-resistant pseudoephedrine product, Zephrex-D.

March 6, 2013

Acura Pharmaceuticals announced that its next-generation pseudoephedrine with abuse-deterrent technology will now be stocked by North Carolina's Kerr Drug.

March 6, 2013

Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors.

March 1, 2013

The Consumer Healthcare Products Association on Friday released a statement regarding a poll released last week by the Asthma and Allergy Foundation of America.

February 22, 2013

Patients around the country "strongly" oppose laws that have been proposed to change popular OTC drugs to prescription-only, according to a new survey.

December 27, 2012

In support of its December launch of the pseudoehedrine product Nexafed, Acura Pharmaceuticals recently kicked off a national e-mail campaign to help drive pharmacists to the Nexafed website with content specifically designed for the pharmacist audience, including infographics, graphic representations of study data and a behind-the-scenes look at Nexafed's abuse-deterrent technology.

December 4, 2012

Westport Pharmaceuticals on Tuesday launched Zephrex-D, a tamper-resistant pseudoephedrine-based decongestant that is now available in retail stores throughout the St. Louis region and the state of Missouri.

November 20, 2012

Gov. Steve Beshear on Monday announced the launch of a privately funded, statewide campaign aimed at increasing public awareness about "smurfing," the illegal process of buying products containing pseudoephedrine on behalf of methamphetamine criminals.

November 15, 2012

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.